Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities - Wikidata - awgldk - TriplyDB

Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities

Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities

http://www.wikidata.org/entity/Q35961275

about

Current Mathematical Models for Analyzing Anti-Malarial Antibody Data with an Eye to Malaria Elimination and Eradication Plasmodium knowlesi transmission: integrating quantitative approaches from epidemiology and ecology to understand malaria as a zoonosis Optimal Population-Level Infection Detection Strategies for Malaria Control and Elimination in a Spatial Model of Malaria Transmission Impact of metric and sample size on determining malaria hotspot boundaries Examination of Antibody Responses as a Measure of Exposure to Malaria in the Indigenous Batwa and Their Non-Indigenous Neighbors in Southwestern Uganda.Measuring changes in transmission of neglected tropical diseases, malaria, and enteric pathogens from quantitative antibody levels.Serological signatures of declining exposure following intensification of integrated malaria control in two rural Senegalese communities An analytical approach to reduce between-plate variation in multiplex assays that measure antibodies to Plasmodium falciparum antigens A Sero-epidemiological Approach to Explore Transmission of Mycobacterium ulcerans Implementation and application of a multiplex assay to detect malaria-specific antibodies: a promising tool for assessing malaria transmission in Southeast Asian pre-elimination areas.Mining gut microbiome oligopeptides by functional metaproteome display.Seroprevalence of Antibodies against Plasmodium falciparum Sporozoite Antigens as Predictive Disease Transmission Markers in an Area of Ghana with Seasonal Malaria Transmission.Use of different transmission metrics to describe malaria epidemiology in the highlands of western Kenya.Characterizing Antibody Responses to Plasmodium vivax and Plasmodium falciparum Antigens in India Using Genome-Scale Protein Microarrays THE REAL McCOIL: A method for the concurrent estimation of the complexity of infection and SNP allele frequency for malaria parasites.Longitudinal analysis of antibody responses in symptomatic malaria cases do not mirror parasite transmission in peri-urban area of Cote d'Ivoire between 2010 and 2013.Malaria hotspots defined by clinical malaria, asymptomatic carriage, PCR and vector numbers in a low transmission area on the Kenyan Coast Common asymptomatic and submicroscopic malaria infections in Western Thailand revealed in longitudinal molecular and serological studies: a challenge to malaria elimination Multi-epitope chimeric antigen used as a serological marker to estimate Plasmodium falciparum transmission intensity in the border area of China-Myanmar.Serological markers to measure recent changes in malaria at population level in Cambodia.Serology reveals heterogeneity of Plasmodium falciparum transmission in northeastern South Africa: implications for malaria elimination.The shape of the iceberg: quantification of submicroscopic Plasmodium falciparum and Plasmodium vivax parasitaemia and gametocytaemia in five low endemic settings in Ethiopia.A systematic review on malaria sero-epidemiology studies in the Brazilian Amazon: insights into immunological markers for exposure and protection.Naturally acquired antibody response to Plasmodium falciparum describes heterogeneity in transmission on islands in Lake Victoria.Advancing translational research with next-generation protein microarrays.Quantifying Heterogeneous Malaria Exposure and Clinical Protection in a Cohort of Ugandan Children.Differing rates of antibody acquisition to merozoite antigens in malaria: implications for immunity and surveillance.Towards Development of Improved Serodiagnostics for Tularemia by Use of Francisella tularensis Proteome Microarrays Modelling dynamic change of malaria transmission in holoendemic setting (Dielmo, Senegal) using longitudinal measures of antibody prevalence to Plasmodium falciparum crude schizonts extract Declining malaria transmission differentially impacts on the maintenance of humoral immunity to Plasmodium falciparum in children.Identification of immune signatures predictive of clinical protection from malaria.Sero-catalytic and Antibody Acquisition Models to Estimate Differing Malaria Transmission Intensities in Western Kenya.malERA: An updated research agenda for characterising the reservoir and measuring transmission in malaria elimination and eradication.Dynamics of anti-MSP3 and Pfs230 antibody responses and multiplicity of infection in asymptomatic children from southern Ghana.Study protocol for a cluster randomised controlled factorial design trial to assess the effectiveness and feasibility of reactive focal mass drug administration and vector control to reduce malaria transmission in the low endemic setting of Namibia.Probabilistic data integration identifies reliable gametocyte-specific proteins and transcripts in malaria parasites.Unravelling the immune signature of Plasmodium falciparum transmission-reducing immunity.The use of longitudinal cohorts for studies of dengue viral pathogenesis and protection.Micro-epidemiology of malaria in an elimination setting in Central Vietnam.Convalescent Plasmodium falciparum-specific seroreactivity does not correlate with paediatric malaria severity or Plasmodium antigen exposure.

P2860

Q26771746-11F76912-CD46-4184-A8AA-311C552C42AE Q28071740-15FE7B93-2C9B-429B-9D98-08CF05E127AF Q28552473-AA1465D9-CF5E-4EF8-AA42-05E16C574240 Q30844998-7B63D782-0A48-46AF-BFDE-2F7066F80F67 Q31145194-318DBFC0-141F-4D86-A86F-DE5D0D60C5E6 Q33752038-CD195EDD-EF6C-4E00-A7DF-DC32DBA84810 Q33793094-4905A8FC-4514-4FD3-94FB-C0D4AE3D3356 Q33909630-4EA35D3C-98DC-45B1-A3D3-5236ACCAA870 Q35903981-99F250AC-79E1-4C91-A92B-326ACAB4F6A1 Q36023507-2085904A-ECE8-4AD4-AFB5-D4254A58C139 Q36153085-ED60E06F-27A8-48FA-816D-4EB2DC27E9AE Q36201242-DFCADF2A-C547-4A1D-9C8D-BDC0AA0F5E25 Q36219438-AEB2B32F-D759-4247-86B0-12E2662C62A2 Q36258737-048A25CC-48FE-470E-853E-C508C069ED17 Q36260900-44D2BFD2-807F-49A8-9533-5371EEE2CAF0 Q36292890-A351E840-C349-43E6-A92D-2DBA5583AB07 Q36796894-28B6EC4A-F0FC-433B-AB12-34F1FDC9F237 Q37031586-D06EA45E-CCB4-4960-9DEA-787F31ADE8BD Q37240322-440189CC-BCE9-4C25-AF04-46A96F9F8E4C Q37394822-4843DD14-31F4-4B68-A0AB-0503E2E03627 Q37609854-A6A208B9-17FC-4EA9-A7FB-4F54C3557ACC Q37678695-F875ADEA-D8B4-4824-B1FE-5C470B9FBD6F Q37685993-89C09886-75FE-4EDA-AB4B-4E0BEB89AA8F Q38613292-5406D25A-06F7-47E0-8A43-E404DC82E071 Q38691479-9A1D6DB1-CBC4-4358-BAF7-EE26CD95A9BF Q38853576-36804E3D-A163-48EC-83EE-6A43A63B1450 Q39230991-4031F2A2-7B6A-4EEF-9ABD-592C31C2BACF Q40705741-C4413084-E08B-4AB6-B8D4-4D32E0E91B3E Q41986892-32FF53AC-4BCD-492C-BCDD-F135AF09330F Q41991578-AC7FC300-145E-48B3-B3FF-8277B2ABA6FB Q45944502-0140584E-66FB-4C43-B5B9-EC8CA24EC08E Q47099079-9BB11647-62D2-46B8-8EF9-AD0B06FB5891 Q47157140-483EA8E0-9035-4D67-91AD-1987F40840D8 Q47179255-059B457F-0A9B-4CDA-8FCD-23623D0A3DF8 Q47553004-AD9B708E-B0C5-4BB1-922C-3A1B67696E71 Q48021651-35FB31C6-DC37-46C5-BEAC-B985E3C712A3 Q49732059-36F83CC8-670C-42F6-A011-782DF7A5B3D8 Q51782689-3114BF97-0B25-497C-8246-927CE2A54F85 Q54253318-6704A5E0-C678-4B9D-8B47-B14FF2505E52 Q54986278-E2A73BB5-995B-4C13-9261-E43124A17800

P2860

Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities

http://www.wikidata.org/entity/Q35961275

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Novel serologic biomarkers pro ...... or individuals and communities

@ast

Novel serologic biomarkers pro ...... or individuals and communities

@en

type

label

Novel serologic biomarkers pro ...... or individuals and communities

@ast

Novel serologic biomarkers pro ...... or individuals and communities

@en

prefLabel

Novel serologic biomarkers pro ...... or individuals and communities

@ast

Novel serologic biomarkers pro ...... or individuals and communities

@en

P1433

Q35961275-B31B2D11-81A4-45EE-9BFA-A8B681DE9C71

P1476

Q35961275-7EAB9BD7-82CE-4E41-8DE0-EFCBDD502C3A

P2093

Q35961275-313312A5-945E-4F79-9EFF-FC8139B91D38

Q35961275-6AB02898-5890-4537-A057-FA4B0A5800AA

Q35961275-9A65A140-01F1-425C-A69D-62713B0C9347

Q35961275-9AB2D896-B09A-4EB6-9534-878B4220DCE6

Q35961275-9BE5DD35-5C35-4A73-9CDA-554F13B810E3

Q35961275-D2E69640-1FBC-4E37-9686-919AF0029933

Q35961275-D4F6F482-BE21-4207-8DE8-A91E52D7A6B1

Q35961275-EA2D1E6B-8E06-417A-9F03-19E5FD70F909

P2860

Q35961275-01E8D00B-529A-4F37-B889-255E05D32142

Q35961275-09153EDC-2A89-4310-8234-908293070FB8

Q35961275-095F1833-127C-4EDE-A676-2F73DEA9A4D2

Q35961275-0ADA3EB2-E67C-4373-B75D-9C15AFD4A8CA

Q35961275-0E60C560-425D-468D-A00E-D4FF02FE04DD

Q35961275-161F7060-61DD-46B5-8D28-B8B941034A27

Q35961275-19C1264E-F0AC-4E11-AFC3-F865C0D98E04

Q35961275-1ADA5D5D-2906-4A16-B3DF-61CA1DE800EF

Q35961275-1D4F7DF8-0289-4308-A98E-E74C0F3D6E67

Q35961275-1D52C697-F186-48A9-B56E-5BEDDA354FB4

P304

Q35961275-A29A4FC9-1451-4CFD-82E5-77247EE06C9C

P31

Q35961275-5D200E4D-4A9C-4E01-9B1E-C3EFE8003ACF

P356

Q35961275-2E18972D-883E-4F46-B344-9D1760C378BF

P407

Q35961275-C5044067-950B-4B7E-B7C6-AE50DC7B80C5

P433

Q35961275-33DA753D-67F1-4A2E-8C03-B7B712E619C0

P478

Q35961275-43F93464-8DD9-4143-9B38-4A31DF9D0BCF

P50

Q35961275-15BEF741-6ADE-4FB3-BEC6-1E61F79AAFF7

Q35961275-4C8E1957-F73E-4833-AD52-DD2B77D3CAB4

Q35961275-511202B5-BD7E-4FFD-8DB2-617459A0508F

Q35961275-61DA6D28-F0C3-4915-ADE3-C8D3C0AC3E57

Q35961275-70EE3737-C168-4C69-9966-23FB4E6F593C

Q35961275-811C90FB-04E1-4367-B28D-393E1421F6AF

Q35961275-8C82A1A1-3A10-47EF-88B6-D4871301476F

Q35961275-967EB3D0-8D80-4CEB-A889-F85DB4D57BE0

Q35961275-EB072718-D508-43DE-98AC-D000353471E5

P577

Q35961275-D132A196-6862-4923-AB98-D35E7B923AE7

P5875

Q35961275-6FD2F8D9-23F2-4937-B134-8C4888573F0F

P698

Q35961275-5F6641F0-4150-4155-8A06-44C18CFC82C0

P921

Q35961275-2C1E7DEF-4A37-4980-A050-26CF4D66E873

Q35961275-8ADAF198-451C-4522-92A0-2B3571CE7AF2

P932

Q35961275-D3FE8E7B-E714-408E-9F61-C9FAE52600DF

P356

PNAS.1501705112

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Novel serologic biomarkers pro ...... or individuals and communities

@en

P2093

Alan Hubbard

http://www.w3.org/2001/XMLSchema#string

Bryan Greenhouse

http://www.w3.org/2001/XMLSchema#string

Christopher J Drakeley

http://www.w3.org/2001/XMLSchema#string

Danica A Helb

http://www.w3.org/2001/XMLSchema#string

Isaac Ssewanyana

http://www.w3.org/2001/XMLSchema#string

Kevin K A Tetteh

http://www.w3.org/2001/XMLSchema#string

Peter D Crompton

http://www.w3.org/2001/XMLSchema#string

Philip L Felgner

http://www.w3.org/2001/XMLSchema#string

P2860

A new world malaria map: Plasmodium falciparum endemicity in 2010

The malaria Atlas Project: developing global maps of malaria risk

Acquired immunity to malaria

Incidence and Reproduction Numbers of Pertussis: Estimates from Serological and Social Contact Data in Five European Countries

Targeting asymptomatic malaria infections: active surveillance in control and elimination

Effect of investment in malaria control on child mortality in sub-Saharan Africa in 2002-2008

Annual Plasmodium falciparum entomological inoculation rates (EIR) across Africa: literature survey, Internet access and review

Serological markers suggest heterogeneity of effectiveness of malaria control interventions on Bioko Island, equatorial Guinea

Regularization Paths for Generalized Linear Models via Coordinate Descent

ROCR: visualizing classifier performance in R

P304

E4438-47

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1501705112

http://www.w3.org/2001/XMLSchema#string

P407

P433

32

http://www.w3.org/2001/XMLSchema#string

P478

112

http://www.w3.org/2001/XMLSchema#string

P50

Harriet Mayanja-Kizza

Emmanuel Arinaitwe

Philip J Rosenthal

Jordan W Tappero

P577

2015-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280536063

http://www.w3.org/2001/XMLSchema#string

P698

26216993

http://www.w3.org/2001/XMLSchema#string

P921

Plasmodium falciparum

P932

4538641

http://www.w3.org/2001/XMLSchema#string